BMS 200 mg 3631 Pill - blue capsule/oblong, 22mm

Generic Name: atazanavir

Pill with imprint BMS 200 mg 3631 is Blue, Capsule/Oblong and has been identified as Reyataz 200 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 200 mg 3631

Reyataz

Generic Name: atazanavir
Imprint: BMS 200 mg 3631
Strength: 200 mg
Color: Blue
Size: 22.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Protease inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: Bristol-Myers Squibb
Inactive Ingredients: lactose monohydrate, magnesium stearate, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac
Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
00003-3631
54868-4854	Physicians Total Care Inc. (repackager)
54569-5532	A-S Medication Solutions, LLC (repackager)
35356-0207	Lake Erie Medical and Surgical Supply (repackager)